1. Home
  2. NAN vs ARCT Comparison

NAN vs ARCT Comparison

Compare NAN & ARCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAN
  • ARCT
  • Stock Information
  • Founded
  • NAN 1999
  • ARCT 2013
  • Country
  • NAN United States
  • ARCT United States
  • Employees
  • NAN N/A
  • ARCT N/A
  • Industry
  • NAN Investment Managers
  • ARCT Biotechnology: Pharmaceutical Preparations
  • Sector
  • NAN Finance
  • ARCT Health Care
  • Exchange
  • NAN Nasdaq
  • ARCT Nasdaq
  • Market Cap
  • NAN 337.8M
  • ARCT 320.8M
  • IPO Year
  • NAN N/A
  • ARCT N/A
  • Fundamental
  • Price
  • NAN $11.52
  • ARCT $18.06
  • Analyst Decision
  • NAN
  • ARCT Strong Buy
  • Analyst Count
  • NAN 0
  • ARCT 10
  • Target Price
  • NAN N/A
  • ARCT $50.88
  • AVG Volume (30 Days)
  • NAN 74.6K
  • ARCT 499.7K
  • Earning Date
  • NAN 01-01-0001
  • ARCT 11-06-2025
  • Dividend Yield
  • NAN 4.37%
  • ARCT N/A
  • EPS Growth
  • NAN N/A
  • ARCT N/A
  • EPS
  • NAN N/A
  • ARCT N/A
  • Revenue
  • NAN N/A
  • ARCT $122,122,000.00
  • Revenue This Year
  • NAN N/A
  • ARCT N/A
  • Revenue Next Year
  • NAN N/A
  • ARCT $28.92
  • P/E Ratio
  • NAN N/A
  • ARCT N/A
  • Revenue Growth
  • NAN N/A
  • ARCT N/A
  • 52 Week Low
  • NAN $9.11
  • ARCT $8.04
  • 52 Week High
  • NAN $11.34
  • ARCT $25.88
  • Technical
  • Relative Strength Index (RSI)
  • NAN 54.35
  • ARCT 54.73
  • Support Level
  • NAN $10.90
  • ARCT $17.38
  • Resistance Level
  • NAN $11.60
  • ARCT $18.69
  • Average True Range (ATR)
  • NAN 0.06
  • ARCT 0.86
  • MACD
  • NAN -0.56
  • ARCT -1.05
  • Stochastic Oscillator
  • NAN 99.28
  • ARCT 96.76

About NAN Nuveen New York Quality Municipal Income Fund

Nuveen New York Quality Municipal Income Fund is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from regular federal, New York State and New York City income tax and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

Share on Social Networks: